Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2004 Jun;112(8):879–882. doi: 10.1289/ehp.6851

Ultrafine particle deposition in subjects with asthma.

David C Chalupa 1, Paul E Morrow 1, Günter Oberdörster 1, Mark J Utell 1, Mark W Frampton 1
PMCID: PMC1242016  PMID: 15175176

Abstract

Ambient air particles in the ultrafine size range (diameter < 100 nm) may contribute to the health effects of particulate matter. However, there are few data on ultrafine particle deposition during spontaneous breathing, and none in people with asthma. Sixteen subjects with mild to moderate asthma were exposed for 2 hr, by mouthpiece, to ultrafine carbon particles with a count median diameter (CMD) of 23 nm and a geometric standard deviation of 1.6. Deposition was measured during spontaneous breathing at rest (minute ventilation, 13.3 +/- 2.0 L/min) and exercise (minute ventilation, 41.9 +/- 9.0 L/min). The mean +/- SD fractional deposition was 0.76 +/- 0.05 by particle number and 0.69 +/- 0.07 by particle mass concentration. The number deposition fraction increased as particle size decreased, reaching 0.84 +/- 0.03 for the smallest particles (midpoint CMD = 8.7 nm). No differences between sexes were observed. The deposition fraction increased during exercise to 0.86 +/- 0.04 and 0.79 +/- 0.05 by particle number and mass concentration, respectively, and reached 0.93 +/- 0.02 for the smallest particles. Experimental deposition data exceeded model predictions during exercise. The deposition at rest was greater in these subjects with asthma than in previously studied healthy subjects (0.76 +/- 0.05 vs. 0.65 +/- 0.10, p < 0.001). The efficient respiratory deposition of ultrafine particles increases further in subjects with asthma. Key words: air pollution, asthma, deposition, dosimetry, inhalation, ultrafine particles.

Full Text

The Full Text of this article is available as a PDF (137.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson P. J., Wilson J. D., Hiller F. C. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest. 1990 May;97(5):1115–1120. doi: 10.1378/chest.97.5.1115. [DOI] [PubMed] [Google Scholar]
  2. Brown B. W., Jr The crossover experiment for clinical trials. Biometrics. 1980 Mar;36(1):69–79. [PubMed] [Google Scholar]
  3. Brown James S., Zeman Kirby L., Bennett William D. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med. 2002 Nov 1;166(9):1240–1247. doi: 10.1164/rccm.200205-399OC. [DOI] [PubMed] [Google Scholar]
  4. Daigle Christopher C., Chalupa David C., Gibb F. Raymond, Morrow Paul E., Oberdörster Günter, Utell Mark J., Frampton Mark W. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol. 2003 May;15(6):539–552. doi: 10.1080/08958370304468. [DOI] [PubMed] [Google Scholar]
  5. Frampton M. W. Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans. Environ Health Perspect. 2001 Aug;109 (Suppl 4):529–532. doi: 10.1289/ehp.01109s4529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gavett S. H., Koren H. S. The role of particulate matter in exacerbation of atopic asthma. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):109–112. doi: 10.1159/000053685. [DOI] [PubMed] [Google Scholar]
  7. Jaques P. A., Kim C. S. Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol. 2000 Aug;12(8):715–731. doi: 10.1080/08958370050085156. [DOI] [PubMed] [Google Scholar]
  8. Karol Meryl H. Respiratory allergy: what are the uncertainties? Toxicology. 2002 Dec 27;181-182:305–310. doi: 10.1016/s0300-483x(02)00298-6. [DOI] [PubMed] [Google Scholar]
  9. Kim C. S., Kang T. C. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. Am J Respir Crit Care Med. 1997 Mar;155(3):899–905. doi: 10.1164/ajrccm.155.3.9117024. [DOI] [PubMed] [Google Scholar]
  10. Morris J. F., Koski A., Johnson L. C. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis. 1971 Jan;103(1):57–67. doi: 10.1164/arrd.1971.103.1.57. [DOI] [PubMed] [Google Scholar]
  11. Oberdorster G., Gelein R. M., Ferin J., Weiss B. Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol. 1995 Jan-Feb;7(1):111–124. doi: 10.3109/08958379509014275. [DOI] [PubMed] [Google Scholar]
  12. Paek D., McCool F. D. Breathing patterns during varied activities. J Appl Physiol (1985) 1992 Sep;73(3):887–893. doi: 10.1152/jappl.1992.73.3.887. [DOI] [PubMed] [Google Scholar]
  13. Penttinen P., Timonen K. L., Tiittanen P., Mirme A., Ruuskanen J., Pekkanen J. Number concentration and size of particles in urban air: effects on spirometric lung function in adult asthmatic subjects. Environ Health Perspect. 2001 Apr;109(4):319–323. doi: 10.1289/ehp.01109319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Peters A., Wichmann H. E., Tuch T., Heinrich J., Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med. 1997 Apr;155(4):1376–1383. doi: 10.1164/ajrccm.155.4.9105082. [DOI] [PubMed] [Google Scholar]
  15. Pope C. Arden, 3rd, Burnett Richard T., Thurston George D., Thun Michael J., Calle Eugenia E., Krewski Daniel, Godleski John J. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2003 Dec 15;109(1):71–77. doi: 10.1161/01.CIR.0000108927.80044.7F. [DOI] [PubMed] [Google Scholar]
  16. Svartengren M., Anderson M., Bylin G., Philipson K., Camner P. Regional deposition of 3.6-micron particles and lung function in asthmatic subjects. J Appl Physiol (1985) 1991 Dec;71(6):2238–2243. doi: 10.1152/jappl.1991.71.6.2238. [DOI] [PubMed] [Google Scholar]
  17. Tobin M. J., Chadha T. S., Jenouri G., Birch S. J., Gazeroglu H. B., Sackner M. A. Breathing patterns. 2. Diseased subjects. Chest. 1983 Sep;84(3):286–294. doi: 10.1378/chest.84.3.286. [DOI] [PubMed] [Google Scholar]
  18. Wilson F. J., Jr, Hiller F. C., Wilson J. D., Bone R. C. Quantitative deposition of ultrafine stable particles in the human respiratory tract. J Appl Physiol (1985) 1985 Jan;58(1):223–229. doi: 10.1152/jappl.1985.58.1.223. [DOI] [PubMed] [Google Scholar]
  19. de Hartog J. J., Hoek G., Peters A., Timonen K. L., Ibald-Mulli A., Brunekreef B., Heinrich J., Tiittanen P., van Wijnen J. H., Kreyling W. Effects of fine and ultrafine particles on cardiorespiratory symptoms in elderly subjects with coronary heart disease: the ULTRA study. Am J Epidemiol. 2003 Apr 1;157(7):613–623. doi: 10.1093/aje/kwg021. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES